SCIENCE
Common supplements rival antibiotics for severe gum disease
ScienceDailySunday, August 30, 2026 at 2:35 PM
RedScroll Brief

Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal.
RedScroll Signal
- Impact
- High
- Category
- Science
- Market relevance
- None
- Why it matters
- Scientific signal separates durable discovery from noise — and often foreshadows policy and product. Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal.
Why it matters
Scientific signal separates durable discovery from noise — and often foreshadows policy and product.
Background
ScienceDaily reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
ScienceDaily published: Common supplements rival antibiotics for severe gum disease
Story is in today’s RedScroll edition. Follow the original source for updates.
More on
Related stories
- The leap second is dead. Long live the leap hour?
NatureSCIENCE
- Order from disorder: do we need a new law of physics?
NatureSCIENCE
- Scale of snakebites estimated globally
NatureSCIENCE
- What’s your lab’s archetype? The answer could inform how you use AI
NatureSCIENCE
- Why are rich people so pessimistic? What the numbers say
NatureSCIENCE
- AI models are being used to track zoonotic diseases. Will they prevent the next pandemic?
NatureSCIENCE
Source
ScienceDaily
Original reporting by ScienceDaily. RedScroll provides an extractive briefing only.